AbbVie Pharmaceutical Fill Finish Manufacturing

AbbVie Pharmaceutical Fill Finish Manufacturing

AbbVie Pharmaceutical Fill Finish Manufacturing offers a range of solutions in biologics development and manufacturing. We aim to improve the global pharmaceutical capability through a fully integrated production facility that offers fill and finish services, drug substance development and contract manufacturing at one location.

AbbVie’s new aseptic fill/finish vial line is situated in Sligo, Ireland. This state-of-the-art line facility supplies biopharmaceutical products to meet growing manufacturing demands from global pharmaceutical companies. We offer services to clients throughout the year, including small batches for clinical trials to large-scale shipments for commercial manufacture.

AbbVie Medicine Fill Finish

AbbVie Pharmaceutical offers medicine fill-finish with advanced cGMP facilities - providing clinical and commercial products based on mammalian cell culture. All processes are cGMP-compliant and follow the guidelines of the U.S. FDA, EMA, and local authorities. Our dedication to quality and optimal services is visible in everything we do, from small-scale clinical trials to large-scale commercial manufacturing.

AbbVie biologics contract manufacturing offers services such as cell line generation, process and analytical method development and analytical services at its facilities. Our other services include clinical and commercial bulk current good manufacturing practice (cGMP), manufacturing of drug substances and drug products. All these with quality assurance, quality control, regulatory compliance standards, and support for our dear customers.

Drug Fill Finish 

Drug producers need to constantly deliver on all these fronts and more, without undermining speed-to-market, to manage a successful pharmaceutical program. The direct benefits of pharmaceutical outsourcing and contract manufacturing allows developers to access both modern technology and accelerate the time to market.

When making a new chemical entity, we ensure precise dosing and drug delivery as this is crucial for success. Regulatory agencies and clinicians want to see well-characterized, reliable doses with good bioavailability. Consumers also often opt for a controlled release dosage form, with simple packaging and taste-free consumption

Our Technical Capability

AbbVie Contract Manufacturing holds to the heart thring our biotech and specialty pharmaceutical clients quick access to manufacturing the highest levels of technical capability, quality, regulatory compliance. We understand the complex nature of sterile manufacturing of biological drug products and we do not take this for granted on every project we undertake.

With our wealth of experience dealing with biologics, AbbVie Contract Manufacturing is competent across all areas of parenteral formulation and sterile contract manufacturing, including biomolecule product formulation, suspension, lyophilized dosage form development, process development, and solution.

AbbVie Contract Manufacturing provides biologics contract manufacturing using innovative filling line technologies that are specifically built to protect your biologic integrity and optimize your API yield. Our manufacturing optimization meets the needs of your biologic molecules with 100% in-line, constructive weight checking; high-yield process design; dual filling technologies, and advanced cold-chain filling.

At AbbVie, we have biopharmaceutical manufacturing plants that accommodate stainless steel bioreactors with high capacities designed and built to carry rapid high protein production. We have suites for upstream, downstream, aseptic fill and finish units, as well as long-term cold storage capacity. Leverage our experience to give your product an edge.